Yemen

Yemen

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
5.46 (4.93 - 6) 2019 Modelled IHME
5.55 (5.01 - 6.09) 2018 Modelled IHME
5.62 (5.06 - 6.19) 2017 Modelled IHME
5.66 (5.11 - 6.25) 2016 Modelled IHME
5.71 (5.15 - 6.35) 2015 Modelled IHME
5.79 (5.24 - 6.42) 2014 Modelled IHME
5.9 (5.36 - 6.54) 2013 Modelled IHME
6.04 (5.46 - 6.69) 2012 Modelled IHME
6.2 (5.59 - 6.86) 2011 Modelled IHME
6.37 (5.73 - 7.07) 2010 Modelled IHME
6.56 (5.89 - 7.25) 2009 Modelled IHME
6.79 (6.11 - 7.51) 2008 Modelled IHME
7.04 (6.34 - 7.81) 2007 Modelled IHME
7.3 (6.56 - 8.15) 2006 Modelled IHME
7.56 (6.76 - 8.46) 2005 Modelled IHME
7.83 (7.01 - 8.77) 2004 Modelled IHME
8.12 (7.25 - 9.10) 2003 Modelled IHME
8.41 (7.50 - 9.41) 2002 Modelled IHME
8.69 (7.72 - 9.77) 2001 Modelled IHME
8.93 (7.90 - 10.06) 2000 Modelled IHME
9.14 (8.11 - 10.29) 1999 Modelled IHME
9.33 (8.31 - 10.50) 1998 Modelled IHME
9.51 (8.49 - 10.70) 1997 Modelled IHME
9.68 (8.60 - 10.89) 1996 Modelled IHME
9.83 (8.66 - 11.07) 1995 Modelled IHME
9.96 (8.82 - 11.26) 1994 Modelled IHME
10.09 (8.92 - 11.42) 1993 Modelled IHME
10.21 (9.03 - 11.57) 1992 Modelled IHME
10.32 (9.10 - 11.74) 1991 Modelled IHME
10.41 (9.15 - 11.90) 1990 Modelled IHME
4.89 (3.92 - 6.23) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.63 (1.28 - 2.01) 2019 Modelled IHME
2.1 (1.65 - 2.59) 2018 Modelled IHME
2.3 (1.79 - 2.88) 2017 Modelled IHME
2.26 (1.79 - 2.77) 2016 Modelled IHME
2.21 (1.73 - 2.72) 2015 Modelled IHME
2.18 (1.72 - 2.67) 2014 Modelled IHME
2.16 (1.70 - 2.65) 2013 Modelled IHME
2.15 (1.69 - 2.64) 2012 Modelled IHME
2.14 (1.68 - 2.64) 2011 Modelled IHME
2.13 (1.66 - 2.63) 2010 Modelled IHME
2.15 (1.68 - 2.64) 2009 Modelled IHME
2.18 (1.72 - 2.68) 2008 Modelled IHME
2.24 (1.77 - 2.77) 2007 Modelled IHME
2.32 (1.85 - 2.87) 2006 Modelled IHME
2.42 (1.93 - 3) 2005 Modelled IHME
2.8 (2.23 - 3.45) 2004 Modelled IHME
3.56 (2.84 - 4.37) 2003 Modelled IHME
4.49 (3.57 - 5.52) 2002 Modelled IHME
5.38 (4.26 - 6.60) 2001 Modelled IHME
6 (4.75 - 7.39) 2000 Modelled IHME
6.4 (5.09 - 7.83) 1999 Modelled IHME
6.75 (5.38 - 8.25) 1998 Modelled IHME
7.05 (5.63 - 8.65) 1997 Modelled IHME
7.3 (5.79 - 8.92) 1996 Modelled IHME
7.49 (5.95 - 9.15) 1995 Modelled IHME
7.65 (6.11 - 9.34) 1994 Modelled IHME
7.79 (6.23 - 9.49) 1993 Modelled IHME
7.91 (6.41 - 9.67) 1992 Modelled IHME
8 (6.48 - 9.76) 1991 Modelled IHME
8.04 (6.47 - 9.94) 1990 Modelled IHME
2.54 (1.82 - 3.54) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,429,800 (1,256,390 - 1,634,100) 1990 Modelled IHME
1,466,160 (1,292,880 - 1,668,330) 1991 Modelled IHME
1,500,040 (1,326,880 - 1,698,770) 1992 Modelled IHME
1,531,350 (1,353,560 - 1,731,830) 1993 Modelled IHME
1,560,030 (1,380,650 - 1,763,240) 1994 Modelled IHME
1,586,220 (1,397,790 - 1,786,700) 1995 Modelled IHME
1,609,610 (1,430,470 - 1,811,660) 1996 Modelled IHME
1,629,570 (1,454,240 - 1,833,160) 1997 Modelled IHME
1,646,120 (1,465,110 - 1,852,690) 1998 Modelled IHME
1,659,270 (1,473,280 - 1,867,850) 1999 Modelled IHME
1,669,030 (1,475,800 - 1,881,230) 2000 Modelled IHME
1,672,080 (1,486,240 - 1,879,780) 2001 Modelled IHME
1,667,160 (1,486,920 - 1,866,090) 2002 Modelled IHME
1,657,420 (1,480,030 - 1,857,340) 2003 Modelled IHME
1,646,430 (1,473,950 - 1,845,460) 2004 Modelled IHME
1,638,170 (1,465,520 - 1,835,280) 2005 Modelled IHME
1,630,820 (1,465,440 - 1,820,980) 2006 Modelled IHME
1,621,230 (1,460,220 - 1,799,930) 2007 Modelled IHME
1,611,830 (1,451,540 - 1,783,810) 2008 Modelled IHME
1,605,420 (1,441,800 - 1,774,340) 2009 Modelled IHME
1,605,190 (1,444,080 - 1,780,520) 2010 Modelled IHME
1,608,590 (1,448,870 - 1,779,920) 2011 Modelled IHME
1,612,120 (1,456,530 - 1,784,070) 2012 Modelled IHME
1,618,040 (1,468,020 - 1,793,910) 2013 Modelled IHME
1,628,690 (1,474,970 - 1,805,410) 2014 Modelled IHME
1,646,460 (1,486,310 - 1,832,360) 2015 Modelled IHME
1,672,090 (1,508,620 - 1,846,710) 2016 Modelled IHME
1,696,580 (1,527,490 - 1,870,700) 2017 Modelled IHME
1,711,340 (1,545,470 - 1,880,260) 2018 Modelled IHME
1,719,000 (1,553,740 - 1,889,930) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.12 (2.01 - 4.67) 2019 Modelled IHME
3.03 (1.98 - 4.53) 2018 Modelled IHME
2.96 (1.90 - 4.42) 2017 Modelled IHME
2.95 (1.88 - 4.34) 2016 Modelled IHME
3.01 (1.89 - 4.45) 2015 Modelled IHME
3.14 (1.98 - 4.67) 2014 Modelled IHME
3.36 (2.09 - 5.08) 2013 Modelled IHME
3.61 (2.23 - 5.46) 2012 Modelled IHME
3.86 (2.34 - 5.83) 2011 Modelled IHME
4.05 (2.45 - 6.21) 2010 Modelled IHME
4.27 (2.56 - 6.49) 2009 Modelled IHME
4.44 (2.61 - 6.74) 2008 Modelled IHME
4.53 (2.63 - 6.87) 2007 Modelled IHME
4.63 (2.67 - 7.19) 2006 Modelled IHME
4.74 (2.67 - 7.50) 2005 Modelled IHME
4.87 (2.69 - 7.81) 2004 Modelled IHME
5.01 (2.73 - 8.07) 2003 Modelled IHME
5.18 (2.78 - 8.65) 2002 Modelled IHME
5.3 (2.75 - 9.04) 2001 Modelled IHME
5.48 (2.76 - 9.55) 2000 Modelled IHME
5.68 (2.82 - 10.30) 1999 Modelled IHME
5.94 (2.89 - 11.10) 1998 Modelled IHME
6.31 (3.03 - 12) 1997 Modelled IHME
6.65 (3.07 - 13.10) 1996 Modelled IHME
6.92 (3.20 - 13.90) 1995 Modelled IHME
7.1 (3.26 - 14.90) 1994 Modelled IHME
7.32 (3.28 - 15.60) 1993 Modelled IHME
7.54 (3.35 - 16.10) 1992 Modelled IHME
7.7 (3.39 - 16.80) 1991 Modelled IHME
7.83 (3.48 - 17.10) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
982 (633 - 1,472) 2019 Modelled IHME
935 (611 - 1,396) 2018 Modelled IHME
893 (573 - 1,335) 2017 Modelled IHME
873 (556 - 1,282) 2016 Modelled IHME
869 (546 - 1,285) 2015 Modelled IHME
882 (556 - 1,314) 2014 Modelled IHME
922 (574 - 1,393) 2013 Modelled IHME
962 (595 - 1,457) 2012 Modelled IHME
1,001 (607 - 1,511) 2011 Modelled IHME
1,020 (617 - 1,564) 2010 Modelled IHME
1,044 (626 - 1,589) 2009 Modelled IHME
1,055 (619 - 1,600) 2008 Modelled IHME
1,043 (606 - 1,583) 2007 Modelled IHME
1,036 (597 - 1,608) 2006 Modelled IHME
1,029 (579 - 1,625) 2005 Modelled IHME
1,024 (565 - 1,643) 2004 Modelled IHME
1,023 (557 - 1,649) 2003 Modelled IHME
1,026 (551 - 1,715) 2002 Modelled IHME
1,019 (529 - 1,740) 2001 Modelled IHME
1,023 (516 - 1,786) 2000 Modelled IHME
1,032 (512 - 1,862) 1999 Modelled IHME
1,048 (510 - 1,964) 1998 Modelled IHME
1,081 (518 - 2,061) 1997 Modelled IHME
1,106 (510 - 2,184) 1996 Modelled IHME
1,116 (517 - 2,244) 1995 Modelled IHME
1,112 (511 - 2,339) 1994 Modelled IHME
1,111 (498 - 2,370) 1993 Modelled IHME
1,107 (492 - 2,369) 1992 Modelled IHME
1,094 (481 - 2,387) 1991 Modelled IHME
1,075 (478 - 2,341) 1990 Modelled IHME
1,426 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
32 (24 - 42) 2019 Modelled IHME
32 (24 - 42) 2018 Modelled IHME
32 (24 - 41) 2017 Modelled IHME
32 (24 - 41) 2016 Modelled IHME
32 (24 - 42) 2015 Modelled IHME
32 (24 - 42) 2014 Modelled IHME
32 (24 - 42) 2013 Modelled IHME
32 (24 - 42) 2012 Modelled IHME
33 (25 - 42) 2011 Modelled IHME
33 (25 - 43) 2010 Modelled IHME
33 (25 - 43) 2009 Modelled IHME
33 (25 - 43) 2008 Modelled IHME
33 (25 - 43) 2007 Modelled IHME
33 (25 - 43) 2006 Modelled IHME
34 (25 - 43) 2005 Modelled IHME
34 (25 - 43) 2004 Modelled IHME
34 (25 - 43) 2003 Modelled IHME
34 (25 - 43) 2002 Modelled IHME
34 (25 - 43) 2001 Modelled IHME
34 (25 - 44) 2000 Modelled IHME
34 (25 - 44) 1999 Modelled IHME
34 (25 - 44) 1998 Modelled IHME
34 (25 - 45) 1997 Modelled IHME
34 (25 - 45) 1996 Modelled IHME
35 (25 - 46) 1995 Modelled IHME
35 (25 - 46) 1994 Modelled IHME
35 (25 - 46) 1993 Modelled IHME
35 (25 - 46) 1992 Modelled IHME
35 (25 - 46) 1991 Modelled IHME
34 (25 - 46) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
65 2018 Survey/reported WHO/UNICEF
68 2017 Survey/reported WHO/UNICEF
71 2016 Survey/reported WHO/UNICEF
69 2015 Survey/reported WHO/UNICEF
73 2014 Survey/reported WHO/UNICEF
73 2013 Survey/reported WHO/UNICEF
67 2012 Survey/reported WHO/UNICEF
69 2011 Survey/reported WHO/UNICEF
76 2010 Survey/reported WHO/UNICEF
76 2009 Survey/reported WHO/UNICEF
78 2008 Survey/reported WHO/UNICEF
79 2007 Survey/reported WHO/UNICEF
78 2006 Survey/reported WHO/UNICEF
80 2005 Survey/reported WHO/UNICEF
43 2004 Survey/reported WHO/UNICEF
38 2003 Survey/reported WHO/UNICEF
31 2002 Survey/reported WHO/UNICEF
19 2001 Survey/reported WHO/UNICEF
14 2000 Survey/reported WHO/UNICEF
9 1999 Survey/reported WHO/UNICEF
73 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.89 (0.72 - 1.08) 2019 Modelled IHME
0.85 (0.70 - 1.01) 2018 Modelled IHME
0.83 (0.69 - 0.99) 2017 Modelled IHME
0.83 (0.70 - 0.99) 2016 Modelled IHME
0.84 (0.70 - 1) 2015 Modelled IHME
0.84 (0.71 - 1) 2014 Modelled IHME
0.85 (0.71 - 1) 2013 Modelled IHME
0.85 (0.71 - 1.01) 2012 Modelled IHME
0.85 (0.71 - 1.01) 2011 Modelled IHME
0.85 (0.71 - 1.02) 2010 Modelled IHME
0.89 (0.74 - 1.06) 2009 Modelled IHME
0.96 (0.80 - 1.15) 2008 Modelled IHME
1.05 (0.87 - 1.26) 2007 Modelled IHME
1.13 (0.92 - 1.37) 2006 Modelled IHME
1.18 (0.96 - 1.44) 2005 Modelled IHME
1.2 (0.97 - 1.47) 2004 Modelled IHME
1.22 (0.99 - 1.50) 2003 Modelled IHME
1.23 (1 - 1.53) 2002 Modelled IHME
1.24 (1 - 1.55) 2001 Modelled IHME
1.24 (1 - 1.57) 2000 Modelled IHME
1.21 (0.97 - 1.51) 1999 Modelled IHME
1.12 (0.91 - 1.40) 1998 Modelled IHME
1.02 (0.83 - 1.26) 1997 Modelled IHME
0.93 (0.76 - 1.14) 1996 Modelled IHME
0.9 (0.73 - 1.10) 1995 Modelled IHME
0.9 (0.73 - 1.10) 1994 Modelled IHME
0.9 (0.73 - 1.10) 1993 Modelled IHME
0.9 (0.74 - 1.10) 1992 Modelled IHME
0.91 (0.74 - 1.12) 1991 Modelled IHME
0.93 (0.75 - 1.14) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
2.2 (1.10 - 3.50) 2014 Modelled Gower et al, 2014
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
127,695 (103,308 - 155,878) 1990 Modelled IHME
129,912 (105,555 - 158,478) 1991 Modelled IHME
132,917 (108,231 - 161,481) 1992 Modelled IHME
136,554 (111,171 - 166,214) 1993 Modelled IHME
140,639 (114,596 - 171,842) 1994 Modelled IHME
144,969 (117,932 - 177,775) 1995 Modelled IHME
155,360 (126,287 - 190,393) 1996 Modelled IHME
174,697 (142,109 - 216,567) 1997 Modelled IHME
197,918 (160,345 - 247,174) 1998 Modelled IHME
219,315 (176,873 - 274,334) 1999 Modelled IHME
232,503 (187,261 - 292,915) 2000 Modelled IHME
238,733 (192,622 - 297,982) 2001 Modelled IHME
243,970 (197,273 - 303,631) 2002 Modelled IHME
248,353 (201,411 - 306,904) 2003 Modelled IHME
252,033 (204,883 - 310,226) 2004 Modelled IHME
255,185 (207,487 - 311,505) 2005 Modelled IHME
252,578 (206,317 - 305,823) 2006 Modelled IHME
241,913 (200,009 - 290,569) 2007 Modelled IHME
228,225 (190,049 - 272,430) 2008 Modelled IHME
217,228 (180,704 - 258,641) 2009 Modelled IHME
215,355 (178,623 - 257,030) 2010 Modelled IHME
220,621 (183,484 - 262,839) 2011 Modelled IHME
226,246 (188,813 - 268,822) 2012 Modelled IHME
232,008 (194,330 - 275,119) 2013 Modelled IHME
237,637 (199,003 - 281,625) 2014 Modelled IHME
242,809 (203,008 - 287,428) 2015 Modelled IHME
246,437 (206,317 - 293,767) 2016 Modelled IHME
250,346 (207,114 - 298,169) 2017 Modelled IHME
261,324 (215,921 - 312,656) 2018 Modelled IHME
280,255 (227,468 - 340,399) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.26 (2.91 - 6.18) 2019 Modelled IHME
4.21 (2.88 - 6.03) 2018 Modelled IHME
4.13 (2.81 - 5.92) 2017 Modelled IHME
4.04 (2.74 - 5.81) 2016 Modelled IHME
3.99 (2.72 - 5.75) 2015 Modelled IHME
3.95 (2.64 - 5.70) 2014 Modelled IHME
3.95 (2.63 - 5.71) 2013 Modelled IHME
3.94 (2.61 - 5.78) 2012 Modelled IHME
3.94 (2.59 - 5.79) 2011 Modelled IHME
3.94 (2.55 - 5.81) 2010 Modelled IHME
4.01 (2.54 - 5.90) 2009 Modelled IHME
4.04 (2.64 - 5.96) 2008 Modelled IHME
4.02 (2.63 - 5.94) 2007 Modelled IHME
4.03 (2.59 - 5.93) 2006 Modelled IHME
4.05 (2.59 - 6.01) 2005 Modelled IHME
4.08 (2.60 - 6.20) 2004 Modelled IHME
4.12 (2.62 - 6.29) 2003 Modelled IHME
4.17 (2.63 - 6.39) 2002 Modelled IHME
4.18 (2.59 - 6.41) 2001 Modelled IHME
4.21 (2.59 - 6.44) 2000 Modelled IHME
4.22 (2.63 - 6.50) 1999 Modelled IHME
4.2 (2.63 - 6.34) 1998 Modelled IHME
4.24 (2.65 - 6.39) 1997 Modelled IHME
4.26 (2.67 - 6.28) 1996 Modelled IHME
4.28 (2.66 - 6.36) 1995 Modelled IHME
4.3 (2.67 - 6.40) 1994 Modelled IHME
4.33 (2.69 - 6.39) 1993 Modelled IHME
4.38 (2.75 - 6.44) 1992 Modelled IHME
4.42 (2.77 - 6.54) 1991 Modelled IHME
4.48 (2.83 - 6.56) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,342 (918 - 1,947) 2019 Modelled IHME
1,299 (890 - 1,860) 2018 Modelled IHME
1,247 (847 - 1,787) 2017 Modelled IHME
1,195 (810 - 1,716) 2016 Modelled IHME
1,151 (785 - 1,660) 2015 Modelled IHME
1,111 (744 - 1,604) 2014 Modelled IHME
1,084 (722 - 1,565) 2013 Modelled IHME
1,051 (697 - 1,541) 2012 Modelled IHME
1,023 (671 - 1,502) 2011 Modelled IHME
994 (643 - 1,463) 2010 Modelled IHME
980 (621 - 1,443) 2009 Modelled IHME
960 (627 - 1,415) 2008 Modelled IHME
926 (606 - 1,367) 2007 Modelled IHME
901 (578 - 1,325) 2006 Modelled IHME
877 (562 - 1,302) 2005 Modelled IHME
859 (548 - 1,305) 2004 Modelled IHME
842 (535 - 1,283) 2003 Modelled IHME
827 (521 - 1,267) 2002 Modelled IHME
804 (498 - 1,233) 2001 Modelled IHME
787 (484 - 1,203) 2000 Modelled IHME
767 (477 - 1,180) 1999 Modelled IHME
741 (463 - 1,118) 1998 Modelled IHME
726 (453 - 1,094) 1997 Modelled IHME
709 (445 - 1,044) 1996 Modelled IHME
691 (430 - 1,027) 1995 Modelled IHME
674 (418 - 1,002) 1994 Modelled IHME
658 (409 - 969) 1993 Modelled IHME
643 (403 - 947) 1992 Modelled IHME
628 (394 - 929) 1991 Modelled IHME
615 (389 - 901) 1990 Modelled IHME
504 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
44 (33 - 53) 2019 Modelled IHME
44 (34 - 53) 2018 Modelled IHME
44 (34 - 53) 2017 Modelled IHME
44 (34 - 53) 2016 Modelled IHME
44 (34 - 53) 2015 Modelled IHME
44 (34 - 53) 2014 Modelled IHME
43 (33 - 53) 2013 Modelled IHME
43 (33 - 52) 2012 Modelled IHME
43 (33 - 52) 2011 Modelled IHME
43 (33 - 52) 2010 Modelled IHME
43 (33 - 52) 2009 Modelled IHME
43 (33 - 51) 2008 Modelled IHME
43 (33 - 51) 2007 Modelled IHME
43 (33 - 52) 2006 Modelled IHME
43 (33 - 52) 2005 Modelled IHME
43 (33 - 52) 2004 Modelled IHME
43 (33 - 52) 2003 Modelled IHME
43 (33 - 52) 2002 Modelled IHME
43 (33 - 53) 2001 Modelled IHME
43 (33 - 53) 2000 Modelled IHME
43 (33 - 53) 1999 Modelled IHME
43 (33 - 53) 1998 Modelled IHME
43 (32 - 53) 1997 Modelled IHME
43 (32 - 53) 1996 Modelled IHME
43 (32 - 53) 1995 Modelled IHME
43 (32 - 53) 1994 Modelled IHME
43 (32 - 53) 1993 Modelled IHME
43 (32 - 53) 1992 Modelled IHME
43 (32 - 53) 1991 Modelled IHME
43 (32 - 53) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
982
2019
(633 - 1,472)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,342
2019
(918 - 1,947)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines